The forecast for Genito Urinary System and Sex Hormones sales in Italy shows a declining trend from 2024 onwards, starting at 6.5 US Dollars per capita and declining to 4.8 by 2028. Compared to previous years, there is an evident downward trajectory, with an annual decline rate. This indicates a strong negative growth trend over the five-year forecast period.
Future trends to watch for include potential market stabilization strategies, increased focus on research and development for innovative treatments, and monitoring shifts in healthcare policies that could impact sales dynamics. Additionally, demographic changes and healthcare spending trends could influence this market trajectory.
